0000899243-17-027185.txt : 20171121
0000899243-17-027185.hdr.sgml : 20171121
20171121191350
ACCESSION NUMBER: 0000899243-17-027185
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20171121
FILED AS OF DATE: 20171121
DATE AS OF CHANGE: 20171121
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ISALY SAMUEL D
CENTRAL INDEX KEY: 0001055949
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38293
FILM NUMBER: 171218112
MAIL ADDRESS:
STREET 1: 601 LEXINGTON AVENUE
STREET 2: 54TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ORBIMED ADVISORS LLC
CENTRAL INDEX KEY: 0001055951
STATE OF INCORPORATION: DE
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38293
FILM NUMBER: 171218114
BUSINESS ADDRESS:
STREET 1: 601 LEXINGTON AVENUE
STREET 2: 54TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
BUSINESS PHONE: (212) 739-6400
MAIL ADDRESS:
STREET 1: 601 LEXINGTON AVENUE
STREET 2: 54TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: OrbiMed Capital GP VI LLC
CENTRAL INDEX KEY: 0001682115
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38293
FILM NUMBER: 171218113
BUSINESS ADDRESS:
STREET 1: 601 LEXINGTON AVENUE, 54TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
BUSINESS PHONE: 212-739-6400
MAIL ADDRESS:
STREET 1: 601 LEXINGTON AVENUE, 54TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: scPharmaceuticals Inc.
CENTRAL INDEX KEY: 0001604950
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 465184075
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2400 DISTRICT AVENUE
STREET 2: SUITE 310
CITY: BURLINGTON
STATE: MA
ZIP: 01830
BUSINESS PHONE: 617-517-0730
MAIL ADDRESS:
STREET 1: 2400 DISTRICT AVENUE
STREET 2: SUITE 310
CITY: BURLINGTON
STATE: MA
ZIP: 01830
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-11-21
0
0001604950
scPharmaceuticals Inc.
SCPH
0001055951
ORBIMED ADVISORS LLC
C/O SCPHARMACEUTICALS INC
2400 DISTRICT AVENUE SUITE 310
BURLINGTON
MA
01830
0
0
1
0
0001682115
OrbiMed Capital GP VI LLC
601 LEXINGTON AVENUE (AT 53RD STREET)
54TH FLOOR
NEW YORK
NY
10022-4629
0
0
1
0
0001055949
ISALY SAMUEL D
601 LEXINGTON AVENUE (AT 53RD STREET)
54TH FLOOR
NEW YORK
NY
10022-4629
0
0
1
0
Common Stock
2017-11-21
4
C
0
2576532
A
2576532
I
See Footnotes
Common Stock
2017-11-21
4
P
0
833333
14.00
A
3409865
I
See Footnotes
Series B Preferred Stock
2017-11-21
4
C
0
18500000
0.00
D
Common Stock
2576532
0
I
See Footnotes
Represents the total number of shares of Common Stock received by OrbiMed Private Investments VI, L.P. ("OPI VI"), upon conversion of the Issuer's Series B Preferred Stock in connection with the closing of the Issuer's initial public offering.
These securities are held of record by OPI VI. OrbiMed Capital GP VI LLC ("GP VI") is the sole general partner of OPI VI, and OrbiMed Advisors LLC ("Advisors") is the managing member of GP VI. Samuel D. Isaly, a natural person, is a managing member of and owner of a controlling interest in Advisors. By virtue of such relationships, GP VI, Advisors and Mr. Isaly may be deemed to have voting and investment power over the securities held by OPI VI and as a result may be deemed to have beneficial ownership over such securities.
This report on Form 4 is jointly filed by GP VI, Advisors and Isaly. Each of the reporting persons disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its or his pecuniary interest therein, if any. This report shall not be deemed an admission that any of the reporting persons is a beneficial owner of such securities for the purposes of Section 16 of the Exchange Act, or for any other purposes.
All series of Convertible Preferred Stock automatically converted into the Issuer's Common Stock on a 7.180193-for-1 basis on November 21, 2017 and had no expiration date.
/s/ Courtney Gaughan, Attorney-in-Fact
2017-11-21